CIK 0001838821
ARYD ARYA Sciences Acquisition Corp IV
Insider trading from SEC Form 4. Last filing Jul 31, 2024.
In brief
ARYA Sciences Acquisition Corp IV (ARYD) has 8 SEC Form 4 filings on file from 6 insiders, the latest filed on Jul 31, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at ARYA Sciences Acquisition Corp IV, scored.
Transactions
Every row filed, 12 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 31, 2024 | Michael Seth Altman Chief Financial Officer | DDisposition to issuer Class A ordinary sharesindirect: By ARYA Sciences Holdings IV | -499,000 | - | - | 0 | Jul 31, 2024 |
| Jul 31, 2024 | ARYA Sciences Holdings IV owner | DDisposition to issuer Class A ordinary shares | -499,000 | - | - | 0 | Jul 31, 2024 |
| Jul 31, 2024 | Todd Wider director | DDisposition to issuer Class B ordinary sharesderivative | -30,000 | - | - | 0 | Jul 31, 2024 |
| Jul 31, 2024 | Leslie Trigg director | DDisposition to issuer Class B ordinary sharesderivative | -30,000 | - | - | 0 | Jul 31, 2024 |
| Jul 31, 2024 | Michael Thomas Henderson director | DDisposition to issuer Class B ordinary sharesderivative | -30,000 | - | - | 0 | Jul 31, 2024 |
| Jul 31, 2024 | Adam Leo Stone Chief Executive Officer | DDisposition to issuer Class A ordinary sharesindirect: By ARYA Sciences Holdings IV | -499,000 | - | - | 0 | Jul 31, 2024 |
| Jul 31, 2024 | Michael Seth Altman Chief Financial Officer | DDisposition to issuer Class B ordinary sharesderivativeindirect: By ARYA Sciences Holdings IV | -1,000,000 | - | - | 2,647,500 | Jul 31, 2024 |
| Jul 31, 2024 | ARYA Sciences Holdings IV owner | DDisposition to issuer Class B ordinary sharesderivative | -1,000,000 | - | - | 2,647,500 | Jul 31, 2024 |
| Jul 31, 2024 | Adam Leo Stone Chief Executive Officer | DDisposition to issuer Class B ordinary sharesderivativeindirect: By ARYA Sciences Holdings IV | -1,000,000 | - | - | 2,647,500 | Jul 31, 2024 |
| Jul 31, 2024 | Michael Seth Altman Chief Financial Officer | DDisposition to issuer Class B ordinary sharesderivativeindirect: By ARYA Sciences Holdings IV | -2,647,500 | - | - | 0 | Jul 31, 2024 |
| Jul 31, 2024 | ARYA Sciences Holdings IV owner | DDisposition to issuer Class B ordinary sharesderivative | -2,647,500 | - | - | 0 | Jul 31, 2024 |
| Jul 31, 2024 | Adam Leo Stone Chief Executive Officer | DDisposition to issuer Class B ordinary sharesderivativeindirect: By ARYA Sciences Holdings IV | -2,647,500 | - | - | 0 | Jul 31, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Michael Seth AltmanChief Financial Officer
- ARYA Sciences Holdings IVowner
- Michael Thomas Hendersonceo, officer, director
- Adam Leo StoneChief Executive Officer
- Leslie Triggceo, chair, officer, director
- Todd Widerdirector
Questions about ARYD
Answered from the filings on this page, as of the latest one.
Are insiders buying ARYD?
No. In the last 90 days no insider at ARYA Sciences Acquisition Corp IV bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade ARYD on the open market?
No open-market trade has been scored at ARYA Sciences Acquisition Corp IV. The latest Form 4 on file was filed on Jul 31, 2024 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at ARYA Sciences Acquisition Corp IV?
6 people have filed a Form 4 at ARYA Sciences Acquisition Corp IV, among them Michael Seth Altman (Chief Financial Officer), ARYA Sciences Holdings IV (10% owner), Michael Thomas Henderson (CEO and director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.